Open Access
How to translate text using browser tools
23 February 2017 RABiT-II: Implementation of a High-Throughput Micronucleus Biodosimetry Assay on Commercial Biotech Robotic Systems
Mikhail Repin, Sergey Pampou, Charles Karan, David J. Brenner, Guy Garty
Author Affiliations +
Abstract

We demonstrate the use of high-throughput biodosimetry platforms based on commercial high-throughput/high-content screening robotic systems. The cytokinesis-block micronucleus (CBMN) assay, using only 20 μl whole blood from a fingerstick, was implemented on a PerkinElmer cell::explorer and General Electric IN Cell Analyzer 2000. On average 500 binucleated cells per sample were detected by our FluorQuantMN software. A calibration curve was generated in the radiation dose range up to 5.0 Gy using the data from 8 donors and 48,083 binucleated cells in total. The study described here demonstrates that high-throughput radiation biodosimetry is practical using current commercial high-throughput/high-content screening robotic systems, which can be readily programmed to perform and analyze robotics-optimized cytogenetic assays. Application to other commercial high-throughput/high-content screening systems beyond the ones used in this study is clearly practical. This approach will allow much wider access to high-throughput biodosimetric screening for large-scale radiological incidents than is currently available.

©2017 by Radiation Research Society.
Mikhail Repin, Sergey Pampou, Charles Karan, David J. Brenner, and Guy Garty "RABiT-II: Implementation of a High-Throughput Micronucleus Biodosimetry Assay on Commercial Biotech Robotic Systems," Radiation Research 187(4), 502-508, (23 February 2017). https://doi.org/10.1667/RR011CC.1
Accepted: 1 January 2017; Published: 23 February 2017
Back to Top